ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 4187 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 3916
1 LEFLUNOMIDE 3809
2 ADALIMUMAB 3801
3 TOCILIZUMAB 3747
4 METHOTREXATE 3739
5 ETANERCEPT 3642
6 INFLIXIMAB 3628
7 CERTOLIZUMAB PEGOL 3576
8 ABATACEPT 3537
9 SULFASALAZINE 3530
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETRIMIDE 83 0.5608
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 171 0.4750
2 200 WET WIPES 322 0.4399
3 PSEUDOEPHEDRINE HYDROCHLORIDE 2300 0.3991
4 CAFFEINE CITRATE 496 0.3704
5 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 90 0.3488
6 PSEUDOEPHEDRINE HCL 2335 0.3467
7 CORTISONE ACETATE 2519 0.3151
8 DESOXIMETASONE 3305 0.2670
9 HYDROCORTISONE PROBUTATE 21 0.2500
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 3809 0.0418
1 Interleukin-6 Receptor Antagonist [EPC] 3778 0.0368
2 Aminosalicylate [EPC] 3533 0.0325
3 Selective T Cell Costimulation Modulator [EPC] 3537 0.0313
4 Histamine-1 Receptor Antagonist [EPC] 1169 0.0288
5 Interleukin-12 Antagonist [EPC] 1986 0.0241
6 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 251 0.0154
7 CD20-directed Cytolytic Antibody [EPC] 3514 0.0145
8 Interleukin-23 Antagonist [EPC] 1986 0.0142
9 Vitamin D [EPC] 3469 0.0133
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE